Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roger M Lyons

Showing results (1-10 of 44) with videos related to

Pageof 5
Sort By:
The American Journal of Medicine|June 28, 2012
Myelodysplastic syndromes: therapy and outlookRoger M Lyons
Clinical Advances in Hematology & Oncology : H&O|April 23, 2009
Recent advances in low- and intermediate-1-risk myelodysplastic syndrome: developing a consensus for optimal therapyRichard Stone, Mikkael Sekeres, Guillermo Garcia-Manero, et al.
Journal of Hematology & Oncology|November 4, 2011
Oral ezatiostat HCl (Telintra®, TLK199) and idiopathic chronic neutropenia (ICN): a case report of complete response of a patient with G-CSF resistant ICN following treatment with ezatiostat, a glutathione S-transferase P1-1 (GSTP1-1) inhibitorRoger M Lyons, Sharon T Wilks, Shelby Young, et al.
Clinical Lymphoma, Myeloma & Leukemia|March 8, 2022
Disease and Clinical Characteristics of Patients With a Clinical Diagnosis of Myelofibrosis Enrolled in the MOST StudyAaron T Gerds, Roger M Lyons, Philomena Colucci, et al.
Case Reports in Hematology|April 30, 2015
Treatment of Acquired von Willebrand Syndrome and Prevention of Bleeding Postautologous Stem Cell Transplant during Severe Pancytopenia with IVIGBehyar Zoghi, Paul Shaughnessy, Roger M Lyons, et al.
Current Medical Research and Opinion|December 20, 2024
Characteristics, blood counts, treatments, and clinical outcomes of 5871 patients with polycythemia vera treated in US community practicesRoger M Lyons, Kathleen M Aguilar, Lavanya Sudharshan, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|September 27, 2006
Secondary prevention of venous thromboembolic events in patients with active cancer: enoxaparin alone versus initial enoxaparin followed by warfarin for a 180-day periodSteven R Deitcher, Craig M Kessler, Geno Merli, et al.
British Journal of Haematology|June 11, 2008
Phase 2, single-arm trial to evaluate the effectiveness of darbepoetin alfa for correcting anaemia in patients with myelodysplastic syndromesJanice Gabrilove, Ronald Paquette, Roger M Lyons, et al.
Pharmacotherapy|November 25, 2005
Low-dose vitamin K to augment anticoagulation controlAlicia M Reese, Lisa E Farnett, Roger M Lyons, et al.
Blood|November 5, 2008
Safety and efficacy of long-term treatment with romiplostim in thrombocytopenic patients with chronic ITPJames B Bussel, David J Kuter, Vinod Pullarkat, et al.
Pageof 5

Showing results (1-10 of 44) with videos related to

Sort By:
Pageof 5
The American Journal of Medicine|June 28, 2012
Myelodysplastic syndromes: therapy and outlookRoger M Lyons
Clinical Advances in Hematology & Oncology : H&O|April 23, 2009
Recent advances in low- and intermediate-1-risk myelodysplastic syndrome: developing a consensus for optimal therapyRichard Stone, Mikkael Sekeres, Guillermo Garcia-Manero, et al.
Journal of Hematology & Oncology|November 4, 2011
Oral ezatiostat HCl (Telintra®, TLK199) and idiopathic chronic neutropenia (ICN): a case report of complete response of a patient with G-CSF resistant ICN following treatment with ezatiostat, a glutathione S-transferase P1-1 (GSTP1-1) inhibitorRoger M Lyons, Sharon T Wilks, Shelby Young, et al.
Clinical Lymphoma, Myeloma & Leukemia|March 8, 2022
Disease and Clinical Characteristics of Patients With a Clinical Diagnosis of Myelofibrosis Enrolled in the MOST StudyAaron T Gerds, Roger M Lyons, Philomena Colucci, et al.
Case Reports in Hematology|April 30, 2015
Treatment of Acquired von Willebrand Syndrome and Prevention of Bleeding Postautologous Stem Cell Transplant during Severe Pancytopenia with IVIGBehyar Zoghi, Paul Shaughnessy, Roger M Lyons, et al.
Current Medical Research and Opinion|December 20, 2024
Characteristics, blood counts, treatments, and clinical outcomes of 5871 patients with polycythemia vera treated in US community practicesRoger M Lyons, Kathleen M Aguilar, Lavanya Sudharshan, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|September 27, 2006
Secondary prevention of venous thromboembolic events in patients with active cancer: enoxaparin alone versus initial enoxaparin followed by warfarin for a 180-day periodSteven R Deitcher, Craig M Kessler, Geno Merli, et al.
British Journal of Haematology|June 11, 2008
Phase 2, single-arm trial to evaluate the effectiveness of darbepoetin alfa for correcting anaemia in patients with myelodysplastic syndromesJanice Gabrilove, Ronald Paquette, Roger M Lyons, et al.
Pharmacotherapy|November 25, 2005
Low-dose vitamin K to augment anticoagulation controlAlicia M Reese, Lisa E Farnett, Roger M Lyons, et al.
Blood|November 5, 2008
Safety and efficacy of long-term treatment with romiplostim in thrombocytopenic patients with chronic ITPJames B Bussel, David J Kuter, Vinod Pullarkat, et al.
Pageof 5